Aquestive Therapeutics, Inc. (AQST)
4.08
-0.09
(-2.16%)
USD |
NASDAQ |
Apr 10, 16:00
4.075
0.00 (0.00%)
After-Hours: 20:00
Aquestive Therapeutics Total Liabilities (Quarterly) : 195.83M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Nektar Therapeutics | 190.57M |
| REGENXBIO, Inc. | 350.30M |
| Verastem, Inc. | 189.24M |
| Harrow, Inc. | 353.12M |
| ACADIA Pharmaceuticals, Inc. | 336.80M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 162.17M |
| Shareholders Equity (Quarterly) | -33.66M |
| Debt to Equity Ratio | -3.905 |
| Current Ratio | 3.135 |
| Net Debt Paydown Yield | -0.30% |